Zimmer Biomet Holdings, Inc. (ZBH) has announced future plans for broadening its offerings by making a definitive contract to acquire Paragon 28 in a $1.1 billion deal. This action was taken with clear intent to diversify and fortify their bio-tech portfolio. Various institutional investors like KBC Group NV, New Wave Wealth Advisors LLC, Sivik Global Healthcare LLC, Gries Financial LLC, Matrix Asset Advisors Inc. NY, Kempner Capital Management Inc., and Lmcg Investments LLC have subsequently increased their share holdings in ZBH. The company also disclosed its quarterly dividend for the fourth quarter of 2024 and strong cash flow outlook. It has also successfully obtained FDA clearance for its revolutionary OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement. Despite facing some market challenges and a 52-week low hit, ZBH stock is projected to benefit significantly from a global expansion plan. Interestingly, the firm has roped in Arnold Schwarzenegger as Chief Movement Officer in what appears to be a landmark partnership.
Zimmer Biomet Holdings ZBH News Analytics from Thu, 02 May 2024 07:00:00 GMT to Sat, 01 Feb 2025 17:52:14 GMT -
Rating 8
- Innovation -2
- Information 6
- Rumor 3
